Bioceres Crop Solutions Corp. (BIOX)
NASDAQ: BIOX · Real-Time Price · USD
0.1730
-0.0099 (-5.41%)
At close: Nov 20, 2026, 4:00 PM EST
0.1750
+0.0020 (1.16%)
After-hours: Nov 20, 2026, 4:57 PM EST
Bioceres Crop Solutions Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 222.74 | 237.84 | 287.66 | 420.44 | 419.45 | 328.46 | |
Revenue Growth | -29.99% | -17.32% | -31.58% | 0.24% | 27.70% | 58.91% |
Cost of Revenue | 153.3 | 156.6 | 186.07 | 267.66 | 241.46 | 203.56 |
Gross Profit | 69.43 | 81.23 | 101.59 | 152.78 | 177.99 | 124.9 |
Selling, General & Admin | 59.67 | 61.27 | 79.57 | 80.72 | 99.4 | 65.31 |
Research & Development | 11 | 11 | 9.36 | 8.22 | 14.89 | 6.86 |
Other Operating Expenses | 16.71 | 17.01 | 12.69 | 16.79 | 10.7 | 14 |
Operating Expenses | 87.37 | 89.27 | 101.62 | 105.73 | 125 | 86.17 |
Operating Income | -17.94 | -8.04 | -0.03 | 47.05 | 52.99 | 38.73 |
Interest Expense | -37.8 | -35.4 | -21.89 | -22.07 | -21.23 | -14.95 |
Earnings From Equity Investments | 1.02 | 0.22 | -1.13 | 4.05 | 1.2 | 1.14 |
Currency Exchange Gain (Loss) | -2.62 | -2.62 | -6.99 | 3.76 | -9.52 | -12.49 |
Other Non Operating Income (Expenses) | -9.86 | -14.06 | -24.24 | -11.56 | -4.33 | 1.64 |
EBT Excluding Unusual Items | -67.2 | -59.9 | -54.27 | 21.22 | 19.11 | 14.06 |
Gain (Loss) on Sale of Assets | -15.58 | -15.58 | 7.75 | - | - | - |
Other Unusual Items | - | - | - | 1.03 | - | - |
Pretax Income | -82.78 | -75.48 | -46.52 | 22.26 | 19.11 | 14.06 |
Income Tax Expense | 5.76 | 6.96 | 2.62 | 6.6 | -1.07 | 17.97 |
Earnings From Continuing Operations | -88.54 | -82.44 | -49.14 | 15.65 | 20.17 | -3.91 |
Earnings From Discontinued Operations | -181.5 | -181.5 | -9.71 | -8.36 | - | - |
Net Income to Company | -270.04 | -263.94 | -58.85 | 7.29 | 20.17 | -3.91 |
Minority Interest in Earnings | 6.59 | 5.79 | 3.43 | -3.01 | -1.39 | -3.29 |
Net Income | -263.45 | -258.15 | -55.42 | 4.28 | 18.78 | -7.2 |
Net Income to Common | -263.45 | -258.15 | -55.42 | 4.28 | 18.78 | -7.2 |
Net Income Growth | - | - | - | -77.23% | - | - |
Shares Outstanding (Basic) | 64 | 64 | 63 | 63 | 62 | 42 |
Shares Outstanding (Diluted) | 64 | 64 | 63 | 63 | 63 | 42 |
Shares Change | 0.59% | 0.66% | -0.40% | 0.47% | 49.37% | 7.86% |
EPS (Basic) | -4.13 | -4.06 | -0.88 | 0.07 | 0.30 | -0.17 |
EPS (Diluted) | -4.13 | -4.06 | -0.88 | 0.07 | 0.30 | -0.17 |
EPS Growth | - | - | - | -77.33% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | - | 64.96 | 44.73 | 33.22 | -8.77 | -20.97 |
Free Cash Flow Per Share | - | 1.02 | 0.71 | 0.52 | -0.14 | -0.50 |
Gross Margin | 31.17% | 34.16% | 35.32% | 36.34% | 42.43% | 38.03% |
Operating Margin | -8.05% | -3.38% | -0.01% | 11.19% | 12.63% | 11.79% |
Profit Margin | -118.28% | -108.54% | -19.26% | 1.02% | 4.48% | -2.19% |
Free Cash Flow Margin | - | 27.31% | 15.55% | 7.90% | -2.09% | -6.39% |
EBITDA | -8.39 | 3.3 | 10.13 | 56.51 | 68.81 | 46.66 |
EBITDA Margin | -3.77% | 1.39% | 3.52% | 13.44% | 16.41% | 14.21% |
D&A For EBITDA | 9.55 | 11.34 | 10.16 | 9.46 | 15.82 | 7.93 |
EBIT | -17.94 | -8.04 | -0.03 | 47.05 | 52.99 | 38.73 |
EBIT Margin | -8.05% | -3.38% | -0.01% | 11.19% | 12.63% | 11.79% |
Effective Tax Rate | - | - | - | 29.67% | - | 127.79% |
Advertising Expenses | - | 1.9 | 3.91 | 4.41 | 5.67 | 4.84 |